Furthermore, apigenin was found to significantly decrease Nrf2 expression in tumor tissue and enhance the sensitivity of tumor xenografts to doxorubicin (Gao et al., 2013a; Gao A. et al., 2013). Here, NFE2L2 is linked to neoplasm.